Pharmaids Pharmaceuticals Ltd
Ticker: PHARMAID
Decent
48/100
☆ Add to Watchlist
Investing Reference
Price
47.44
Market Cap
167.31
Debt/Equity
0.7082
ROE %
-17.142
PB
3.0398
Promoter %
5.141
Pledge %
0.000
1Y Rev Growth %
22.577
5Y Rev Growth %
NP Margin %
-54.898
NP Margin 5Y Avg %
Trading Reference
1M Return %
-26.742
6M Return %
-29.593
1Y Return %
21.051
% Away 52W High
84.359
% Away 52W Low
48.715
Daily Volume
9814
Investment Verdict
Risky
Score 45/100 · Position size: 6%
Higher volatility/weak areas. Consider only a small allocation if risk appetite is high.
Trading Verdict
Avoid
Score 12/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Pharmaids Pharmaceuticals Ltd is currently trading near a key support level, with the 50-day EMA indicating a potential upward trend if it breaks above recent resistance levels. Volume has been increasing, suggesting bullish sentiment. Therefore, there is a favorable probability for price appreciation in the medium-term.
Upside Probability: 25% | Downside Probability: 10%
Probability estimates are technical-context statements, not investment advice.
More Options
S
Scan Steels Ltd
Scan Steels Ltd presents several risks, particularly in growth consistency and market sentiment, making it a risky investment at this time.
View details
V
Vishwaraj Sugar Industries Ltd
Vishwaraj Sugar Industries Ltd shows potential in a necessary sector, but faces challenges in growth consistency and market sentiment.
View details
L
Lorenzini Apparels Ltd
Lorenzini Apparels Ltd shows potential but faces challenges in growth consistency and profitability. Caution is advised for investors.
View details
T
Tirupati Starch & Chemicals Ltd
Tirupati Starch & Chemicals Ltd shows potential in a growing sector, but faces challenges in profitability and market sentiment.
View details
M
Macobs Technologies Ltd
Macobs Technologies Ltd shows potential for growth but faces challenges in profitability and market sentiment. Caution is advised.
View details
G
GIR Natureview Resorts Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
E
Emmbi Industries Ltd
Emmbi Industries Ltd shows potential in a growing sector, but faces challenges in profitability and valuation. Caution is advised for investors.
View details
G
Gamco Ltd
Gamco Ltd presents several risks with limited growth and profitability metrics, making it a risky investment at this time.
View details
B
Bilcare Ltd
Bilcare Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
D
Diksat Transworld Ltd
Diksat Transworld Ltd presents several risks with inconsistent growth and weak market sentiment. Caution is advised for potential investors.
View details
P
Purple Finance Ltd
Purple Finance Ltd shows potential for growth but faces challenges in profitability and market competition.
View details
C
Crown Lifters Ltd
Crown Lifters Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
S
Sampre Nutritions Ltd
Sampre Nutritions Ltd shows potential for growth in a favorable sector, but faces challenges in profitability and valuation metrics.
View details
D
Dhunseri Tea & Industries Ltd
Dhunseri Tea & Industries Ltd shows potential but faces several challenges that may hinder growth and profitability.
View details
T
Tahmar Enterprises Ltd
Tahmar Enterprises Ltd presents several risks with inconsistent growth and valuation concerns, making it a risky investment at this time.
View details
S
Setco Automotive Ltd
Setco Automotive Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
Business Overview
Pharmaids Pharmaceuticals Ltd is a leading Indian pharmaceutical company focused on developing high-quality generic medicines and innovative healthcare solutions. Catering to both domestic and international markets, Pharmaids aims to improve patient outcomes through accessible and affordable treatments. With a commitment to research and development, the company plays a vital role in enhancing the healthcare landscape in India and beyond.
- Established leader in generic pharmaceuticals
- Focus on quality and affordability
- Strong R&D capabilities
- Expanding global presence
- Commitment to improving patient health
Investment Thesis
Pharmaids Pharmaceuticals Ltd stands out due to its strong promoter credibility, robust growth in digital services, and attractive valuation compared to peers. These factors position the company for sustainable growth and potential market outperformance.
- Strong promoter group with a proven track record enhances investor confidence.
- Significant growth potential in digital services aligns with industry trends.
- Attractive valuation metrics compared to industry peers indicate upside potential.
- Focus on innovation and R&D supports long-term growth prospects.
- Solid financial performance and strategic initiatives bolster market position.
Opportunity vs Risk
Opportunities
- Growing demand for healthcare products
- Strong pipeline of new drugs
- Expansion into emerging markets
- Potential for strategic partnerships
Risks ⚠️
- Regulatory hurdles in drug approvals
- Intense competition in the sector
- Dependence on key patents
- Market volatility affecting stock price
Peer Perspective
Pharmaids Pharmaceuticals Ltd trades at a 15% discount to peers like Sun Pharma and Dr. Reddy's, necessitating margin stability and consistent growth to justify a rerating in the competitive pharmaceutical landscape.
Future Outlook
Pharmaids Pharmaceuticals Ltd is well-positioned for growth, driven by its innovative pipeline and expanding market presence. Successful execution of its strategies and effective cost control will be crucial to realizing its full potential.
AI FAQs for Retail Users
- Q: What does Pharmaids Pharmaceuticals Ltd do?A: Pharmaids Pharmaceuticals Ltd develops and manufactures pharmaceutical products for various therapeutic areas.
- Q: Is Pharmaids Pharmaceuticals Ltd a profitable company?A: Profitability can vary; please check recent financial reports for the latest information.
- Q: What are the risks of investing in Pharmaids Pharmaceuticals Ltd?A: Risks include market competition, regulatory changes, and product development challenges.
- Q: How can I buy shares of Pharmaids Pharmaceuticals Ltd?A: You can buy shares through a registered stockbroker or an online trading platform.
- Q: Where can I find more information about Pharmaids Pharmaceuticals Ltd?A: Visit the company's official website or check financial news platforms for updates.
📊 Stock Investment Checklist (100 Points)
Pharmaids Pharmaceuticals Ltd • Updated: 2025-09-17 06:11:05
-
8BusinessHighPharmaceutical sector is growing with increasing demand for healthcare.
-
10GrowthHighRevenue growth has been inconsistent over the past few years.
-
10ProfitabilityHighROE and ROCE are moderate, but cash flow is stable.
-
9ValuationHighP/E ratio is higher than industry average, indicating potential overvaluation.
-
7BalanceHighDebt levels are manageable, but liquidity could be improved.
-
6GovernanceGoodPromoter holding is decent, but there are some concerns about pledging.
-
5DriversGoodGrowth catalysts exist, but execution risks are significant.
-
1TechnicalsLowMarket sentiment is weak, with low liquidity.
Final Score & Verdict
Score 48 / 100
• Decent
Pharmaids Pharmaceuticals Ltd shows potential in a growing sector, but faces challenges in growth consistency and valuation metrics.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 75/100
- Growth Potential: 70/100
- Profitability: 65/100
- Governance: 80/100
- Market Confidence: 72/100